MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Comparing psychosocial risk factors in patients with functional movement disorders and patients with psychogenic non-epileptic seizures

    C.W. Maurer, G.M. Capitan, G. Limachia, K. LaFaver, E. Considine, A. Curran, W.C. LaFrance, M. Hallett (Bethesda, MD, USA)

    Objective: To compare the trauma histories and psychopathological comorbidities in patients with functional (psychogenic) movements disorders (FMD) to patients with psychogenic non-epileptic seizures (PNES). Background:…
  • 2016 International Congress

    Health related quality of life in patient with Parkinson’s disease using deep brain stimulators (DBS)- A cross sectional study

    F. Pullishery, A. Abraham (Malappuram, India)

    Objective: This study aimed to investigate the Health Related Quality of Life before and after the placement of Deep brain stimulators in patients with Parkinson's…
  • 2016 International Congress

    Predictors of clinically meaningful change in PDQ-39 in Parkinson’s disease

    T. Simuni, S. Wu, Y. He, C. Marras, T. Davis, E. Nelson, F. Cubillos, P. Schmidt, On behalf of the NPF QII Investigators (Chicago, IL, USA)

    Objective: To determine predictors of a clinically meaningful change of HRQL of patients with PD. Background: There is limited literature on the baseline and longitudinal…
  • 2016 International Congress

    The care needs project: Understanding the experience of people with Parkinson’s in institutional care and understanding the care needs of people with Parkinson’s

    A. Hand, R.W. Walker, W.K. Gray, L.L. Oates (North Shields, United Kingdom)

    Objective: To look at predictors to care home placement for people with Parkinson's (PD) along with the experience of those already in care and identify…
  • 2016 International Congress

    Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology

    J.L. Alberts, M.M. Koop, S.M. Linder, T. Dey, S.J. Ozinga (Cleveland, OH, USA)

    Objective: To validate the use of a mobile device and an associated biomechanical outcome to objectively quantify postural stability in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Objective data in Parkinson’s disease therapy management – A retrospective analysis of the Parkinson’s kinetigraph (PKG) database

    P. Lynch, Y. Zoellner, S. McGregor, M. Home (Minnetonka, MN, USA)

    Objective: To assess whether patients who received a PKG analysis in routine care featured improved PD symptom scores over time using the PKG central repository.…
  • 2016 International Congress

    Technology use habits and preferences of a population with Parkinson’s disease and their care partners

    J.M. Dean (Boulder, CO, USA)

    Objective: To ascertain the current utilization of Internet, app-based and wearable technologies among individuals with Parkinson's disease. Background: The Davis Phinney Foundation for Parkinson's disseminated…
  • 2016 International Congress

    Expanding the spectrum of ATP1A3 related disorders: Continuum from alternating hemiplegia of childhood to rapid-onset dystonia parkinsonism?

    S.A. Rodríguez-Quiroga, D. González-Moron, S.A. Vishnopolska, G.L. Vigo, M. Cordoba, N. Medina, T. Arakaki, N.S. Garretto, M.A. Kauffman (Caba, Argentina)

    Objective: To report clinical and molecular features of a family showing intrafamilial phenotypic diversity where a novel ATP1A3 mutation was found. Background: Originally there have…
  • 2016 International Congress

    Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease

    C. Max, A. Westenberger, N. Brueggemann, A. Domingo, K. Gruetz, H. Pawlack, A. Weissbach, A.A. Kuehn, J. Spiegler, A.E. Lang, J. Sperner, V.S.C. Fung, J. Schallner, G. Gillessen-Kaesbach, A. Muenchau, C. Klein (Lübeck, Germany)

    Objective: To expand and determine the clinical spectrum associated with mutations in the Adenylate Cyclase 5 gene (ADCY5). Background: Recently, mutations in the ADCY5 gene…
  • 2016 International Congress

    Dopamine D3 receptor Ser9Gly variant is a risk factor for impulse control disorders in Parkinson’s disease

    A. Kishore, S. Krishnamoorthy, R. Rajan, S. Sarma, M. Banerjee (Trivandrum, India)

    Objective: To test if the allelic variants of dopamine (DRD3), glutamate (GRIN2B) and serotonin (HTR2A) receptors are risk factors for ipulse control disorders (ICD) in…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley